Overexpression of alpha synuclein disrupts APP and Endolysosomal axonal trafficking in a mouse model of synucleinopathy
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the axonal trafficking of APP-mCherry was impaired by the expression of toxic α-synuclein in primary mouse neurons”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Tsigelny, I. F., Crews, L., Desplats, P., Shaked, G. M., Sharikov, Y., Mizuno, H., Spencer, B., Rockenstein, E., Trejo, M., Platoshyn, O., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003135 · Cited by 281
Self-citationRetractedRETRACTED: Soluble α-Synuclein Is a Novel Modulator of Alzheimer's Disease Pathophysiology
Larson, M. E., Sherman, M. A., Greimel, S., Kuskowski, M., Schneider, J. A., Bennett, D. A., & Lesné, S. E. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0581-12.2012 · Cited by 128 · cited 1×
“At the molecular level, ASYN may serve as a mediator of A β toxicity to selected neuronal populations (Crews et al., 2009; Larson et al., 2012).”
BackgroundRetractedProbing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells
Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., et al. (2012) · Nature · doi:10.1038/nature10821 · Cited by 1,253 · cited 1×
“This finding is consistent with previous studies demonstrating that β-CTFs of APP impair endosomal trafficking in an early phase of cellular pathogenesis in AD (Cataldo et al., 2003; Israel et al., 2012; Jiang et al., 2019; Kim et al., 2016; Xu et al., 2016).”
ResultThe Lewy body variant of Alzheimer's disease: A clinical and pathologic entity
Hansen, L., Salmon, D., Galasko, D., Masliah, E., Katzman, R., DeTeresa, R., Thal, L., Pay, M. M., Hofstetter, R., Klauber, M., et al. (1990) · Neurology · doi:10.1212/wnl.40.1.1 · Cited by 1,068
Self-citationα-Synuclein impairs macroautophagy: implications for Parkinson’s disease
Winslow, A. R., Chen, C.-W., Corrochano, S., Acevedo-Arozena, A., Gordon, D. E., Peden, A. A., Lichtenberg, M., Menzies, F. M., Ravikumar, B., Imarisio, S., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201003122 · Cited by 825 · cited 2×
“Other studies revealed that ASYN aggregates could be detrimental for the endolysosomal and macroautophay pathways, which S. Lin et al. Neurobiology of Disease 178 (2023) 106010 are involved in their clearance (Tanik et al., 2013; Winslow et al., 2010; Yan et al., 2014).”
BackgroundVolpicelli-Daley, L. A., Luk, K. C., & Lee, V. M.-Y. (2014) · Nature Protocols · doi:10.1038/nprot.2014.143 · Cited by 731 · cited 3×
“…of neuronal proteins into pathological lesions, and that too has been associated with the endo-lysosomal system as a hotspot for aggregate formation, leading to so called ‘enlarged endosomes’ (Chassefeyre et al., 2021; Hu et al., 2015; Soper et al., 2011; Volpicelli-Daley et al., 2014a).”
BackgroundLipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation
Galvagnion, C., Buell, A. K., Meisl, G., Michaels, T. C. T., Vendruscolo, M., Knowles, T. P. J., & Dobson, C. M. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1750 · Cited by 661 · cited 1×
“Our work as well as previous authors suggested that ASYN colocalizes with endosomes within the axon – inclusions could then grow from these membranes (Galvagnion et al., 2015) and selectively trap more vesicles and organelles, explaining the heterogeneity of proteins found in inclusions.”
Masliah, E., Rockenstein, E., Veinbergs, I., Sagara, Y., Mallory, M., Hashimoto, M., & Mucke, L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211412398 · Cited by 607
Self-citationα-synuclein in the pathophysiology of Alzheimer’s disease
Twohig, D., & Nielsen, H. M. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0320-x · Cited by 374
Axonal transport: Driving synaptic function
Guedes-Dias, P., & Holzbaur, E. L. F. (2019) · Science · doi:10.1126/science.aaw9997 · Cited by 355 · cited 1×
“Given that expression of the hASYN transgene delayed axonal trafficking, and synaptic formation is critically dependent on axonal delivery of presynaptic components (Guedes-Dias and Holzbaur, 2019), we set out to investigate whether the hASYN transgene would affect synapse”
Background
Research works printed but not linked: 81
- Araki, 2019, Parkinson’s disease is a type of amyloidosis featuring accumulation of amyloid fibrils of α-synuclein, Proc. Natl. Acad. Sci., 116, 17963, 10.1073/pnas.1906124116 · DOI
- Bachhuber, 2015, Inhibition of amyloid-β plaque formation by α-synuclein, Nat. Med., 21, 802, 10.1038/nm.3885 · DOI
- Berge, 2016, Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer’s disease, mild cognitive impairment, or healthy controls: a two year follow-up study, BMC Neurol., 16, 1, 10.1186/s12883-016-0706-0 · DOI · Paper page
- Blumenstock, 2017, Seeding and transgenic overexpression of alpha-synuclein triggers dendritic spine pathology in the neocortex, EMBO Molecular Medicine, 9, 716, 10.15252/emmm.201607305 · DOI
- Boassa, 2013, Mapping the subcellular distribution of α-synuclein in neurons using genetically encoded probes for correlated light and electron microscopy: implications for Parkinson’s disease pathogenesis, J. Neurosci., 33, 2605, 10.1523/JNEUROSCI.2898-12.2013 · DOI
- Burré, 2010, α-Synuclein promotes SNARE-complex assembly in vivo and in vitro, Science, 329, 1663, 10.1126/science.1195227 · DOI · Paper page
- Burré, 2014, α-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation, Proc. Natl. Acad. Sci., 111, E4274, 10.1073/pnas.1416598111 · DOI · Paper page
- Carnazza, 2022, Synaptic vesicle binding of α-synuclein is modulated by β-and γ-synucleins, Cell Rep., 39, 10.1016/j.celrep.2022.110675 · DOI
- Carnwath, 2018, The direct and indirect effects of α-synuclein on microtubule stability in the pathogenesis of Parkinson’s disease, Neuropsychiatr. Dis. Treat., 14, 1685, 10.2147/NDT.S166322 · DOI
- Caviston, 2007, Huntingtin facilitates dynein/dynactin-mediated vesicle transport, Proceedings of the National Academy of Sciences, 104, 10045, 10.1073/pnas.0610628104 · DOI · Paper page
- Chassefeyre, 2021, Endosomal sorting drives the formation of axonal prion protein endoggresomes, Sci. Adv., 7, eabg3693, 10.1126/sciadv.abg3693 · DOI
- Chen, 1995, The human NACP/α-synuclein gene: chromosome assignment to 4q21. 3–q22 and TaqI RFLP analysis, Genomics, 26, 425, 10.1016/0888-7543(95)80237-G · DOI
- Chu, 2012, Alterations in axonal transport motor proteins in sporadic and experimental Parkinson’s disease, Brain, 135, 2058, 10.1093/brain/aws133 · DOI · Paper page
- Crews, 2009, Role of synucleins in Alzheimer’s disease, Neurotox. Res., 16, 306, 10.1007/s12640-009-9073-6 · DOI
- Das, 2013, Activity-induced convergence of APP and BACE-1 in acidic microdomains via an endocytosis-dependent pathway, Neuron, 79, 447, 10.1016/j.neuron.2013.05.035 · DOI · Paper page
- Devi, 2010, Mitochondrial trafficking of APP and alpha synuclein: relevance to mitochondrial dysfunction in Alzheimer’s and Parkinson’s diseases, Biochim. Biophys. Acta, 1802, 11, 10.1016/j.bbadis.2009.07.007 · DOI
- Diao, 2013, Native α-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2, elife, 2, 10.7554/eLife.00592 · DOI · Paper page
- Duce, 2010, Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease, Cell, 142, 857, 10.1016/j.cell.2010.08.014 · DOI · Paper page
- Fakhree, 2021, The localization of alpha-synuclein in the endocytic pathway, Neuroscience, 457, 186, 10.1016/j.neuroscience.2021.01.017 · DOI
- Fang, 2017, Synuclein impairs trafficking and signaling of BDNF in a mouse model of Parkinson’s disease, Sci. Rep., 7, 1
- Ferman, 2018, The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies, Alzheimers Dement., 14, 330, 10.1016/j.jalz.2017.09.014 · DOI
- Froula, 2018, α-Synuclein fibril-induced paradoxical structural and functional defects in hippocampal neurons, Acta Neuropathologica Communications, 6, 1, 10.1186/s40478-018-0537-x · DOI · Paper page
- Galvin, 1999, Axon pathology in Parkinson’s disease and Lewy body dementia hippocampus contains α-, β-, and γ-synuclein, Proc. Natl. Acad. Sci., 96, 13450, 10.1073/pnas.96.23.13450 · DOI · Paper page
- Gao, 2018, The emerging role of Rab GTPases in the pathogenesis of Parkinson’s disease, Mov. Disord., 33, 196, 10.1002/mds.27270 · DOI
- Gonçalves, 2017, Traffic jams and the complex role of α-Synuclein aggregation in Parkinson disease, Small GTPases, 8, 78, 10.1080/21541248.2016.1199191 · DOI
- Gonçalves, 2016, shRNA-based screen identifies endocytic recycling pathway components that act as genetic modifiers of alpha-synuclein aggregation, secretion and toxicity, PLoS Genet., 12, 10.1371/journal.pgen.1005995 · DOI
- Hamilton, 2000, Lewy bodies in Alzheimer’s disease: a neuropathological review of 145 cases using α-synuclein immunohistochemistry, Brain Pathol., 10, 378, 10.1111/j.1750-3639.2000.tb00269.x · DOI · Paper page
- Hansen, 2013, A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP, Neurobiol. Dis., 56, 145, 10.1016/j.nbd.2013.04.017 · DOI
- Hansen, 1993, Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa, J. Neuropathol. Exp. Neurol., 52, 648, 10.1097/00005072-199311000-00012 · DOI · Paper page
- Houlden, 2012, The genetics and neuropathology of Parkinson’s disease, Acta Neuropathol., 124, 325, 10.1007/s00401-012-1013-5 · DOI · Paper page
- Hu, 2015, The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration, Translational Neurodegeneration, 4, 1, 10.1186/s40035-015-0041-1 · DOI · Paper page
- Hunn, 2015, Impaired intracellular trafficking defines early Parkinson’s disease, Trends Neurosci., 38, 178, 10.1016/j.tins.2014.12.009 · DOI · Paper page
- Iwai, 1996, The synaptic protein NACP is abnormally expressed during the progression of Alzheimer’s disease, Brain Res., 720, 230, 10.1016/0006-8993(96)00014-5 · DOI
- Jellinger, 2011, Interaction between ?-Synuclein and other proteins in neurodegenerative disorders, TheScientificWorldJournal, 11, 1893, 10.1100/2011/371893 · DOI
- Kang, 2017, TrkB neurotrophic activities are blocked by α-synuclein, triggering dopaminergic cell death in Parkinson’s disease, Proc. Natl. Acad. Sci., 114, 10773, 10.1073/pnas.1713969114 · DOI · Paper page
- Kaul, 2011, Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson’s disease, BMC Neurosci., 12, 1, 10.1186/1471-2202-12-79 · DOI
- Kim, 2016, Evidence that the rab5 effector APPL1 mediates APP-βCTF-induced dysfunction of endosomes in down syndrome and Alzheimer’s disease, Mol. Psychiatry, 21, 707, 10.1038/mp.2015.97 · DOI · Paper page
- Kim, 2021, Dysregulation of mitochondria-lysosome contacts by GBA1 dysfunction in dopaminergic neuronal models of Parkinson’s disease, Nat. Commun., 12, 1
- Kwart, 2019, A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP β-CTFs, not Aβ, Neuron, 104
- Leitão, 2021, Selectivity of Lewy body protein interactions along the aggregation pathway of α-synuclein, Commun Biol, 4, 1124, 10.1038/s42003-021-02624-x · DOI
- Majbour, 2017, Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease, Sci. Rep., 7, 1, 10.1038/srep40263 · DOI · Paper page
- Maroteaux, 1988, Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal, J. Neurosci., 8, 2804, 10.1523/JNEUROSCI.08-08-02804.1988 · DOI · Paper page
- Marui, 2000, Occurrence of human α-synuclein immunoreactive neurons with neurofibrillary tangle formation in the limbic areas of patients with Alzheimer’s disease, J. Neurol. Sci., 174, 81, 10.1016/S0022-510X(99)00327-5 · DOI
- Masaracchia, 2018, Membrane binding, internalization, and sorting of alpha-synuclein in the cell, Acta Neuropathologica Communications, 6, 1, 10.1186/s40478-018-0578-1 · DOI
- Mazzulli, 2016, α-Synuclein–induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models, Proc. Natl. Acad. Sci., 113, 1931, 10.1073/pnas.1520335113 · DOI · Paper page
- Mikolaenko, 2005, Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore longitudinal study of aging (BLSA), J. Neuropathol. Exp. Neurol., 64, 156, 10.1093/jnen/64.2.156 · DOI · Paper page
- Mullin, 2015, The genetics of Parkinson’s disease, Br. Med. Bull., 114, 39, 10.1093/bmb/ldv022 · DOI
- Navarro-Romero, 2020, The emerging role of the lysosome in Parkinson’s disease, Cells, 9, 2399, 10.3390/cells9112399 · DOI
- Ono, 2012, Cross-seeding effects of amyloid β-protein and α-synuclein, J. Neurochem., 122, 883, 10.1111/j.1471-4159.2012.07847.x · DOI · Paper page
- Osterberg, 2015, Progressive aggregation of alpha-synuclein and selective degeneration of lewy inclusion-bearing neurons in a mouse model of parkinsonism, Cell Rep., 10, 1252, 10.1016/j.celrep.2015.01.060 · DOI · Paper page
- Overk, 2014, Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5–implications for dementia with Lewy bodies, Mol. Neurodegener., 9, 1, 10.1186/1750-1326-9-18 · DOI
- Pensalfini, 2020, Endosomal dysfunction induced by directly overactivating Rab5 recapitulates prodromal and neurodegenerative features of Alzheimer’s disease, Cell Rep., 33, 10.1016/j.celrep.2020.108420 · DOI
- Price, 2016, Longitudinal live imaging of retinal α-synuclein:: GFP deposits in a transgenic mouse model of Parkinson’s Disease/Dementia with Lewy Bodies, Sci. Rep., 6, 1, 10.1038/srep29523 · DOI
- Price, 2018, The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s disease, Sci. Rep., 8, 1, 10.1038/s41598-018-34490-9 · DOI · Paper page
- Roberts, 2017, α-Synuclein increases β-amyloid secretion by promoting β−/γ-secretase processing of APP, PLoS One, 12, 10.1371/journal.pone.0171925 · DOI
- Rockenstein, 2005, Lysosomal pathology associated with α-synuclein accumulation in transgenic models using an eGFP fusion protein, J. Neurosci. Res., 80, 247, 10.1002/jnr.20446 · DOI
- Rodrigues, 2012, Enhanced β-secretase processing alters APP axonal transport and leads to axonal defects, Hum. Mol. Genet., 21, 4587, 10.1093/hmg/dds297 · DOI · Paper page
- Sahin, 2006, The distribution pattern of pathology and cholinergic deficits in amygdaloid complex in Alzheimer’s disease and dementia with Lewy bodies, Acta Neuropathol., 111, 115, 10.1007/s00401-005-0003-2 · DOI
- Schützmann, 2021, Endo-lysosomal Aβ concentration and pH trigger formation of Aβ oligomers that potently induce tau missorting, Nat. Commun., 12, 1, 10.1038/s41467-021-24900-4 · DOI · Paper page
- Scott, 2010, A pathologic cascade leading to synaptic dysfunction in α-synuclein-induced neurodegeneration, J. Neurosci., 30, 8083, 10.1523/JNEUROSCI.1091-10.2010 · DOI · Paper page
- Shen, 2018, Dynactin is involved in Lewy body pathology, Neuropathology, 38, 583, 10.1111/neup.12512 · DOI
- Shen, 2020, Upregulation of RIN3 induces endosomal dysfunction in Alzheimer’s disease, Translational Neurodegeneration, 9, 1, 10.1186/s40035-020-00206-1 · DOI
- Sheng, 2012, Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration, Nat. Rev. Neurosci., 13, 77, 10.1038/nrn3156 · DOI · Paper page
- Shi, 2017, Rab GTPases: the key players in the molecular pathway of Parkinson’s disease, Front. Cell. Neurosci., 11, 81, 10.3389/fncel.2017.00081 · DOI
- Soper, 2011, Aggregation of α-synuclein in S. cerevisiae is associated with defects in endosomal trafficking and phospholipid biosynthesis, J. Mol. Neurosci., 43, 391, 10.1007/s12031-010-9455-5 · DOI
- Spencer, 2016, Reducing endogenous α-synuclein mitigates the degeneration of selective neuronal populations in an Alzheimer’s disease transgenic mouse model, J. Neurosci., 36, 7971, 10.1523/JNEUROSCI.0775-16.2016 · DOI · Paper page
- Spencer, 2019, Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease, Neurobiol. Dis., 127, 163, 10.1016/j.nbd.2019.03.001 · DOI
- Spinelli, 2014, Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson’s disease, J. Neurosci., 34, 2037, 10.1523/JNEUROSCI.2581-13.2014 · DOI
- Stokin, 2005, Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease, Science, 307, 1282, 10.1126/science.1105681 · DOI · Paper page
- Taguchi, 2019, Expression of α-synuclein is regulated in a neuronal cell type-dependent manner, Anat. Sci. Int., 94, 11, 10.1007/s12565-018-0464-8 · DOI
- Teixeira, 2021, Alpha-Synuclein and the endolysosomal system in parkinson’s disease: guilty by association, Biomolecules, 11, 1333, 10.3390/biom11091333 · DOI
- Twohig, 2019, α-Synuclein in the pathophysiology of Alzheimer’s disease, Mol. Neurodegener., 14, 23, 10.1186/s13024-019-0320-x · DOI · Paper page
- Vingtdeux, 2007, Intracellular pH regulates amyloid precursor protein intracellular domain accumulation, Neurobiol. Dis., 25, 686, 10.1016/j.nbd.2006.09.019 · DOI
- Volpicelli-Daley, 2011, Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death, Neuron, 72, 57, 10.1016/j.neuron.2011.08.033 · DOI · Paper page
- Volpicelli-Daley, 2014, Formation of α-synuclein Lewy neurite–like aggregates in axons impedes the transport of distinct endosomes, Mol. Biol. Cell, 25, 4010, 10.1091/mbc.e14-02-0741 · DOI · Paper page
- Xu, 2016, Amyloid precursor protein–mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration, J. Clin. Invest., 126, 1815, 10.1172/JCI82409 · DOI · Paper page
- Xu, 2018, Dysregulation of Rab5-mediated endocytic pathways in Alzheimer's disease, Traffic, 19, 253, 10.1111/tra.12547 · DOI
- Yan, 2014, Overexpression of human E46K mutant α-synuclein impairs macroautophagy via inactivation of JNK1-Bcl-2 pathway, Mol. Neurobiol., 50, 685, 10.1007/s12035-014-8738-1 · DOI
- Yim, 2015, The multivesicular body is the major internal site of prion conversion, J. Cell Sci., 128, 1434, 10.1242/jcs.165472 · DOI
- Zhang, 2013, Defective axonal transport of Rab7 GTPase results in dysregulated trophic signaling, J. Neurosci., 33, 7451, 10.1523/JNEUROSCI.4322-12.2013 · DOI · Paper page
- Zhao, 2016, TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington’s disease, Proc. Natl. Acad. Sci., 113, E5655, 10.1073/pnas.1603020113 · DOI
Cited by
Wang, J., Fourriere, L., & Gleeson, P. A. (2024) · Biochemical Journal · doi:10.1042/bcj20240056 · Cited by 27
Metadata
- Authors
- Lin, S., Leitão, A. D. G., Fang, S., Gu, Y., Barber, S., Gilliard-Telefoni, R., Castro, A., Sung, K., Shen, R., Florio, J. B., Mante, M. L., Ding, J., Spencer, B., Masliah, E., Rissman, R. A., & Wu, C.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2023-03
- Volume
- 178
- Pages
- 106010
- ISSN
- 0969-9961
- Cited by
- 17
- References
- 20
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Overexpression of alpha synuclein disrupts APP and Endolysosomal axonal trafficking in a mouse model of synucleinopathy. https://app.cochat.ai/papers/10.1016/j.nbd.2023.106010
- The paper
- Lin, S., Leitão, A. D. G., Fang, S., Gu, Y., Barber, S., Gilliard-Telefoni, R., Castro, A., Sung, K., Shen, R., Florio, J. B., Mante, M. L., Ding, J., Spencer, B., Masliah, E., Rissman, R. A., & Wu, C. (2023). Overexpression of alpha synuclein disrupts APP and Endolysosomal axonal trafficking in a mouse model of synucleinopathy. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2023.106010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.